Request Information
To request more information about this product, please complete the form below.
Featured Product
Advertisement
Illumina Connected Insights
The Connected Insights software harnesses extensive knowledge sources via powerful API-integrations for streamlined variant interpretation, including prioritization of relevant clinical trials, drug labels, and guidelines for clinical research. Control over your standardized workflows enables flexibility, and automation speeds your time to relevant insights with procedural consistency. Connected Insights helps you address the interpretation bottleneck and move our understanding of disease forward.
Product Specifications
Platform compatibility
Broad spectrum of NGS systems and robust APIs for implementing within digital ecosystems, including EHR/EMR
Data input compatiibiliity
VCF from DRAGEN software or any other secondary analysis solution with seamless data flow
Assay compatibility
Wide range of DNA or RNA assays with VCF output; supports solid tumor assays, Assay compatibility liquid biopsy assays, hematological malignancy testing, panels, WES, WGS, and whole-transcriptome sequencing
Variant classes
Small variants (SNVs, indels), CNVs, SVs, fusions, LOH, and splice site variants
Genomic signatures
TMB, MSI, HRD (GIS), and tumor ploidy
External knowledge sources
> 55 sources, including CKB from Genomenon, OncoKB, COSMIC, CIViC, ClinVar, LitVar, and Mastermind
Comprehensive filtering
Includes variant frequency, quality scores, read depth, variant type, functional impact, and others
Automation and classification
Supports variant filter presents for key test parameters, VICC guideline-based oncogenicity prediction, and draft report generation
User-friendly reporting
Enables generation of custom reports that can be optimized based on disease research focu
Visualizations
IGV, genome plots for SVs, CNVs, coverage and B-allele ratio, Circos plots, VAF distribution, fusion plots, and more
Featured Content
About Illumina, Inc.
At Illumina, our mission is to improve human health by unlocking the power of the genome. Our sequencing by synthesis chemistry is used to generate high-accuracy sequence data in studies around the globe. Our microarrays also provide accurate, high-throughput genotyping for a range of applications. The innovative products that we provide are facilitating breakthroughs in many scientific areas, including oncology, reproductive health, genetic disease, precision medicine, agriculture, microbiology, and beyond. The progress we see being made in genomics inspires us to push the boundaries of what is possible so we can create the next generation of genomics solutions.
Interested in seeing more content from Illumina, Inc.?
Discover all their latest news, webinars, products and more by clicking the link below.
